-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On October 15, Buchang Pharmaceutical issued an announcement stating that in order to meet Buchang Pharmaceutical’s future business development needs, promote the smooth implementation of the company’s overall strategy, enhance the company’s overall operating environment and external image, and realize the company’s planning, the company and its wholly-owned subsidiaries Shenzhou Pharmaceutical plans to acquire 100% equity of Beijing Chengrui
details as follows:
1.
The equity transfer payment for the acquisition is 20,444,121.
2.
3.
The company issued a notice of the sixth meeting of the fourth board of directors on October 11, 2021, and was convened by communication at 13:00 on October 14, 2021.
The acquisition does not constitute a major asset reorganization as required by the Measures for the Administration of Major Asset Reorganizations of Listed Companies, nor does it constitute a connected transaction